1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus

समान संसाधन

• Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
  द्वारा: Abdul-Mutakabbir, Jacinda C., और अन्य
  प्रकाशित: (2020)
• The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
  द्वारा: Morrisette, Taylor, और अन्य
  प्रकाशित: (2020)
• 2391. Liposomal Vancomycin and Cefazolin Combinations for S. aureus Biofilms
  द्वारा: Kebriaei, Razieh, और अन्य
  प्रकाशित: (2018)
• Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model
  द्वारा: Kebriaei, Razieh, और अन्य
  प्रकाशित: (2019)
• 1295. Activity of SPR206, a Polymyxin B Derivative, Compared to Colistin Alone and in Combination Against Multidrug-Resistant Pseudomonas aeruginosa Strains
  द्वारा: Abdul-Mutakabbir, Jacinda C, और अन्य
  प्रकाशित: (2020)